Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

International Journal of Cancer

Volumn 130, Issue 7, 2012, Pages 1620-1628

  Chen, Xi ^a   Hu, Zhibin ^b   Wang, Wenjing ^c   Ba, Yi ^d   Ma, Lijia ^e,f   Zhang, Chunni ^a   Wang, Cheng ^a   Ren, Zhiji ^a   Zhao, Yang ^b   Wu, Sijia ^a   Zhuang, Rui ^a   Zhang, Yixin ^g   Hu, Heng ^c   Liu, Chazhen ^c   Xu, Lin ^h   Wang, Jun ^e,f   Shen, Hongbing ^b   Zhang, Junfeng ^a   Zen, Ke ^a   Zhang, Chen Yu ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Shanghai Municipal Center for Disease Control and Prevention   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e BGI SHENZHEN   (China)

^f Chinese Academy of Sciences   (China)

^g NANTONG TUMOR HOSPITAL   (China)

^h JIANGSU CANCER HOSPITAL   (China)

Author keywords

early diagnosis; noninvasive biomarker; nonsmall cell lung cancer; serum microRNA

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC MARKER; GENOME ANALYSIS; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA FINGERPRINTING; SENSITIVITY AND SPECIFICITY; SMOKING HABIT;

CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84856358368     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26177     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ,. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. (Pubitemid 46148091)
2. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6. (Pubitemid 32911406)
3. Ganti AK, Mulshine JL,. Lung cancer screening. Oncologist 2006; 11: 481-7. (Pubitemid 43788274)
4. Patz EF, Jr., Goodman PC, Bepler G,. Screening for lung cancer. N Engl J Med 2000; 343: 1627-33. (Pubitemid 32162988)
5. Brambilla C, Fievet F, Jeanmart M, de Fraipont F, Lantuejoul S, Frappat V, Ferretti G, Brichon PY, Moro-Sibilot D,. Early detection of lung cancer: role of biomarkers. Eur Respir J Suppl 2003; 39: 36s-44s. (Pubitemid 36125635)
6. Rossi A, Maione P, Colantuoni G, Gaizo FD, Guerriero C, Nicolella D, Ferrara C, Gridelli C,. Screening for lung cancer: New horizons? Crit Rev Oncol Hematol 2005; 56: 311-20. (Pubitemid 41677614)
7. Dominioni L, Imperatori A, Rovera F, Ochetti A, Torrigiotti G, Paolucci M,. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening. Cancer 2000; 89: 2334-44.
8. Oken MM, Marcus PM, Hu P, Beck TM, Hocking W, Kvale PA, Cordes J, Riley TL, Winslow SD, Peace S, Levin DL, Prorok PC, et al., Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial J Natl Cancer Inst 2005; 97: 1832-9. (Pubitemid 43039889)
9. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS,. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355: 1763-71. (Pubitemid 44631359)
10. Mascalchi M, Belli G, Zappa M, Picozzi G, Falchini M, Della Nave R, Allescia G, Masi A, Pegna AL, Villari N, Paci E,. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial. AJ. R Am J Roentgenol 2006; 187: 421-9. (Pubitemid 44148286)
11. Tarro G, Perna A, Esposito C,. Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 2005; 203: 1-5. (Pubitemid 40328166)
12. He L, Hannon GJ,. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-31. (Pubitemid 38868508)
13. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
14. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
15. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66. (Pubitemid 44629897)
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
17. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, et al., Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: e179.
18. Tang F, Hajkova P, Barton SC, Lao K, Surani MA,. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34: e9.
19. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, et al,. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-8.
20. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE,. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-9.
21. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, et al., Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3: e3148.
22. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ,. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58: 1375-81.
23. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL,. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-5. (Pubitemid 351667616)
24. Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, Kreisman H, Quoix E,. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Chest 1995; 108: 163-9.
25. Nisman B, Lafair J, Heching N, Lyass O, Baras M, Peretz T, Barak V,. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?. Cancer 1998; 82: 1850-9. (Pubitemid 28208639)
26. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, et al., A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61. (Pubitemid 43271657)
27. Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G,. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 2008; 27: 3845-55. (Pubitemid 351862062)
28. Hermanek P, Sobin L, eds. TNM classification of malignant tumors, 4th edn. Berlin: Springer-Verlag 1987: 69-73.
29. Mountain CF,. The new International Staging System for Lung Cancer. Surg Clin North Am 1987; 67: 925-35. (Pubitemid 17158573)
30. Naruke T, Goya T, Tsuchiya R, Suemasu K,. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-7.